drugset / Trial / NCT03670082

Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State

NCT03670082

Phase 1 Completed 10 enrolled H. Lundbeck A/S
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate the extent to which Lu AF35700 enters the bloodstream following pill intake and the influence of food on the uptake in healthy men and women

Timeline

Start
2018-09-05
Primary completion
2018-12-21
Completion
2019-01-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AF35700 Unknown 100 ug Oral
Subject Lu AF35700 Unknown 20 mg Oral

Indications

No indication recorded.